Maternal Diet-induced Obesity Programmes Cardiac Dysfunction in Male Mice Independently of Post-weaning Diet
Overview
Authors
Affiliations
Aims: Obesity during pregnancy increases risk of cardiovascular disease (CVD) in the offspring and individuals exposed to over-nutrition during fetal life are likely to be exposed to a calorie-rich environment postnatally. Here, we established the consequences of combined exposure to a maternal and post-weaning obesogenic diet on offspring cardiac structure and function using an established mouse model of maternal diet-induced obesity.
Methods And Results: The impact of the maternal and postnatal environment on the offspring metabolic profile, arterial blood pressure, cardiac structure, and function was assessed in 8-week-old C57BL/6 male mice. Measurement of cardiomyocyte cell area, the transcriptional re-activation of cardiac fetal genes as well as genes involved in the regulation of contractile function and matrix remodelling in the adult heart were determined as potential mediators of effects on cardiac function. In the adult offspring: a post-weaning obesogenic diet coupled with exposure to maternal obesity increased serum insulin (P < 0.0001) and leptin levels (P < 0.0001); maternal obesity (P = 0.001) and a post-weaning obesogenic diet (P = 0.002) increased absolute heart weight; maternal obesity (P = 0.01) and offspring obesity (P = 0.01) caused cardiac dysfunction but effects were not additive; cardiac dysfunction resulting from maternal obesity was associated with re-expression of cardiac fetal genes (Myh7: Myh6 ratio; P = 0.0004), however, these genes were not affected by offspring diet; maternal obesity (P = 0.02); and offspring obesity (P = 0.05) caused hypertension and effects were additive.
Conclusions: Maternal diet-induced obesity and offspring obesity independently promote cardiac dysfunction and hypertension in adult male progeny. Exposure to maternal obesity alone programmed cardiac dysfunction, associated with hallmarks of pathological left ventricular hypertrophy, including increased cardiomyocyte area, upregulation of fetal genes, and remodelling of cardiac structure. These data highlight that the perinatal period is just as important as adult-onset obesity in predicting CVD risk. Therefore, early developmental periods are key intervention windows to reduce the prevalence of CVD.
Pregnancy in obese women and mechanisms of increased cardiovascular risk in offspring.
Cochrane A, Murphy M, Ozanne S, Giussani D Eur Heart J. 2024; 45(48):5127-5145.
PMID: 39508438 PMC: 11663486. DOI: 10.1093/eurheartj/ehae671.
Hossain M, Gao Y, Li X, Zhao L, Liu X, Marie de Avila J EBioMedicine. 2024; 109:105421.
PMID: 39476533 PMC: 11565040. DOI: 10.1016/j.ebiom.2024.105421.
The role of microRNAs in pregnancies complicated by maternal diabetes.
Owen M, Kennedy M, Quilang R, Scott E, Forbes K Clin Sci (Lond). 2024; 138(18):1179-1207.
PMID: 39289953 PMC: 11409017. DOI: 10.1042/CS20230681.
Burden S, Alshehri R, Lamata P, Poston L, Taylor P Int J Obes (Lond). 2024; 48(8):1045-1064.
PMID: 38898228 PMC: 11281905. DOI: 10.1038/s41366-024-01536-0.
Guidelines for in vivo models of developmental programming of cardiovascular disease risk.
Warrington J, Collins H, Davidge S, do Carmo J, Goulopoulou S, Intapad S Am J Physiol Heart Circ Physiol. 2024; 327(1):H221-H241.
PMID: 38819382 PMC: 11380980. DOI: 10.1152/ajpheart.00060.2024.